Daniel Ring

Daniel Ring has over 14 years of experience in the pharmaceutical industry. Daniel began their career in 2007 as the Executive Director of Corporate Licensing at Merck. In 2014, they moved to Exela Pharma Sciences LLC, where they served as the Vice President of Business Development & Licensing. In this role, they were a member of the executive management team, responsible for growing Exela's revenue and income. In 2019, they became the Vice President of Business Development & Strategic Planning at Soligenix, Inc. and in 2021, they became the Executive Director at Bristol Myers Squibb. Currently, they are the Vice President of Business Development & Licensing at AviadoBio.

Daniel Ring completed a Bachelor of Arts degree at Villanova University, followed by a Master of Business Administration degree in Accounting at the Thunderbird School of Global Management.